ENTPD1 and head and neck squamous cell carcinoma: Although only a single case of HNSCC in the ICB cohort had non-metastatic LN samples available post-ICB therapy for MC analysis, we found a remarkably abundant population of CD39+PD-1+ and CD39+ Tpex cells within the CD8+ T cells (Fig. S3I).